Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
10,000+ US Securities
Unlisted Companies not available on US Stock Exchanges
Professionally managed portfolios, designed by Vested’s research team
Get exposure to 50+ countries via global funds managed by the world’s top fund managers
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
The fund is an actively managed exchange-traded fund. The Sub-Adviser concentrates the fund's investments (i.e., invests more than 25% of its net assets) in the securities of issuers in the biotechnology, pharmaceuticals, healthcare technology, and life science tools and services industries. The Sub-Adviser employs an actively managed opportunistic multi-asset strategy that focuses on common stock, preferred stock, convertible bonds, structured notes, corporate notes and bonds, and ETFs that primarily invest in the preceding security types. The fund is non-diversified. more
| Time Frame | SURI | S&P500 |
|---|---|---|
| 1-Week Return | 4.47% | 2.26% |
| 1-Month Return | 12.05% | 7.74% |
| 3-Month Return | 11.86% | 9.51% |
| 6-Month Return | 16.14% | 11.31% |
| 1-Year Return | 30.78% | 27.33% |
| 3-Year Return | -20.59% | 81.24% |
| 5-Year Return | -25% | 79.59% |
| Time Frame | SURI | S&P500 |
|---|---|---|
| 1-Week Return | 877.86% | 220.69% |
| 1-Month Return | 299.19% | 147.70% |
| 3-Month Return | 57.54% | 44.55% |
| 6-Month Return | 35.45% | 24.27% |
| 1-Year Return | 30.78% | 27.33% |
| 3-Year Return | -7.40% | 21.92% |
| 5-Year Return | -5.59% | 12.42% |
| Stock name | Ticker | Weight |
|---|---|---|
PLAINS GP HLDGS L P | PAGP | 38.74% |
ACHIEVE LIFE SCIENCES INC USD 0.001 | ACHV | 8.85% |
MILESTONE PHARMACEUTICALS INC NPV | MIST | 8.5% |
PHATHOM PHARMACEUTICALS USD 0.0001 | PHAT | 4.07% |
ABEONA THERAPEUTICS INC USD 0.01 | ABEO | 3.87% |
DELCATH SYS INC USD 0.01 | DCTH | 3.79% |
CELLDEX THERAPEUTICS INC USD 0.001 | CLDX | 2.62% |
OCULIS HOLDING AG CHF 0.01 | OCS | 2.54% |
CORCEPT THERAPEUTICS INC USD 0.001 | CORT | 2.54% |
ACHIEVE LIFE SCIENCES I WTS 30JUN30 | ACHIEVE.LIFE.SCIENCES.I.WTS.30JUN30 | 2.24% |
Cash | Cash | 1.91% |
LEONABIO INC USD 0.0001 | LONA | 1.81% |
COMPASS PATHWAYS PLC USD 0.008 ADR | CMPS | 1.8% |
KYVERNA THERAPEUTICS IN USD 0.00001 | KYTX | 1.59% |
INVENTIVA SA NPV ADR | IVA | 1.58% |
ZEVRA THERAPEUTICS INC USD 0.0001 | ZVRA | 1.4% |
PALISADE BIO INC USD 0.01 | PALI | 1.37% |
AQUESTIVE THERAPEUTICS IN USD 0.001 | AQST | 1.28% |
ORCHESTRA BIOMED HLDGS I USD 0.0001 | OBIO | 1.16% |
TELSAT 5.625 12/06/26 144A Corp | TELSAT.5.625.12.06.26.144A.Corp | 1.14% |
OCULAR THERAPEUTIX INC USD 0.0001 | OCUL | 1.01% |
EYEPOINT INC | EYPT | 0.92% |
SAB BIOTHERAPEUTICS INC USD 0.0001 | SABS | 0.92% |
TREVI THERAPEUTICS INC USD 0.001 | TRVI | 0.78% |
UPSTREAM BIO INC USD 0.001 | UPB | 0.73% |
IMMUNIC INC USD 0.0001 | IMUX | 0.62% |
AKERO THERAPEUTICS INC CVR | AKERO.THERAPEUTICS.INC.CVR | 0.55% |
ACHIEVE LIFE SCIENCES WTS | ACHIEVE.LIFE.SCIENCES.WTS | 0.41% |
ARTIVA BIOTHERAPEUTICS I USD 0.0001 | ARTV | 0.37% |
OVID THERAPEUTICS INC USD 0.001 | OVID | 0.35% |
KALARIS THERAPEUTICS INC USD 0.0001 | KLRS | 0.27% |
WTS - MILESTONE PHARMACEUTICALS INC SERIES B | WTS...MILESTONE.PHARMACEUTICALS.INC.SERIES.B | 0.23% |
ALTIMMUNE INC | ALTIMMUNE.INC | 0.03% |
CONTRA CHINOOK THERAPE + NPV | CONTRA.CHINOOK.THERAPE...NPV | 0% |
EIGER BIOPHARMACEUTICALS USD 0.0001 | EIGRQ | 0% |
JASPER THERAPEUTIC WTS | JASPER.THERAPEUTIC.WTS | 0% |
WTS - QUOIN PHARMACEUTICALS LTD - Series H | WTS...QUOIN.PHARMACEUTICALS.LTD...Series.H | 0% |
WTS - QUOIN PHARMACEUTICALS LTD - Series I | WTS...QUOIN.PHARMACEUTICALS.LTD...Series.I | 0% |
WTS - QUOIN PHARMACEUTICALS LTD - Series J | WTS...QUOIN.PHARMACEUTICALS.LTD...Series.J | 0% |
WTS - QUOIN PHARMACEUTICALS LTD - Series K | WTS...QUOIN.PHARMACEUTICALS.LTD...Series.K | 0% |
WTS - TENAYA THERAPEUTICS INC | WTS...TENAYA.THERAPEUTICS.INC | 0% |
| Sector | Weight |
|---|---|
|
Health care | 58.56% |
|
Energy | 41.44% |
Simplify Propel Opportunities ETF (SURI) share price today is $18.065.
Yes, Indians can buy shares of Simplify Propel Opportunities ETF (SURI) on Vested. To buy SURI from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Simplify Propel Opportunities ETF (SURI) on Vested. You can start investing in Simplify Propel Opportunities ETF (SURI) with a minimum investment of $1.
The 52-week high price of Simplify Propel Opportunities ETF (SURI) is $18.5. The 52-week low price of Simplify Propel Opportunities ETF (SURI) is $12.05.
The stock symbol (or ticker) of Simplify Propel Opportunities ETF is SURI.
Yes, you can setup SIP in Simplify Propel Opportunities ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of SURI on the Vested app.
The expense ratio of Simplify Propel Opportunities ETF (SURI) is 2.51%.
Link copied